Skip to content

Palliative Sedation across European settings - a prospective observational multicentre study

Palliative Sedation across European settings - a prospective observational multicentre study - PALSED

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON52485
Enrollment
110
Registered
2020-06-02
Start date
2021-06-04
Completion date
Unknown
Last updated
2024-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alle patienten met een primaire diagnose van kanker Cancer patients at the end of life with untreatable symptoms Terminal cancer patients with refractory symptoms

Interventions

None listed

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * Age 18 years or above; * Primary diagnosis at admission is advanced cancer; * Life expectancy of the patient is limited (clinical prognosis estimation 1-2 months); * Intractable distress caused by one or more refractory symptoms during the hospitalization can be expected or is present, according the health care team; * Able to give informed consent, or there is a possibility of proxy informed consent.

Exclusion criteria

Exclusion criteria: * When a potential participant is unable to give informed consent and there is no possibility of proxy informed consent, he/she is not eligible for participation in this study. * When a potential participant and/or the relative is unable to speak and read in the native language of the participating country, he/she is not eligible for participation in this study.

Design outcomes

Primary

MeasureTime frame
Change in discomfort levels of patients receiving palliative sedation, measured by the health care professionals using the DS-DAT, a Discomfort Score for patients with Dementia Alzheimer Type. Measured before and twice a day during the whole procedure of palliative sedation until death. This measure has been succesfully applied in sedated patients in previous studies, for example from Radboudumc.

Secondary

MeasureTime frame
Depth of sedation and levels of agitation are measured with the Richmond Agitation Sedation Scale, modified version for palliative care (RASS-PALL).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)